col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


128 Results       Page 1

 [1] 
Elsevier: International Journal of Cardiology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jun―18 Exercise response in post-acute coronary syndrome patients survived to COVID-19 infection Giovanni Provenzale, Lucia Barbieri, Gabriele Tumminello, Stefano Carugo, Marco Guazzi
2 [GO] 2023―Dec―29 The impact of obesity on thromboembolic (TE) complications among COVID-19 patients in the intensive care unit (ICU) Z. Hanis Hanum, M. Nur Farhani, A.H.Z. Izzati, C.K. Lee, S.E. Kar, R. Tharmini, P. Mohan
3 [GO] 2023―Dec―29 Procedural setting of percutaneous coronary intervention in Malaysia during the SARS-COV-2 pandemic - data from The National Heart Association of Malaysia's NCVD-PCI Registry R.E. Raja Shariff, S.S. Kasim, K.T. Liu, G. Selvaraj, M.S. Mohamed, G. Mahadevan, W.A. Wan Ahmad
4 [GO] 2023―Nov―17 Exercise capacity following SARS-CoV-2 infection is related to changes in cardiovascular and lung function in military personnel Rebecca R. Chamley, Jennifer L. Holland, Jonathan Collins, Kayleigh Pierce, William D. Watson, Peregrine G. Green, et al. (+9)
5 [GO] 2023―Nov―11 The mechanistic insights into new-onset atrial fibrillation induced by SARS-CoV-2 infection Xiaoxia Xiao
6 [GO] 2023―Sep―28 Overview of SARS-CoV-2 infection and vaccine associated myocarditis compared to non-COVID-19-associated myocarditis: A systematic review and meta-analysis Yoshiko Ishisaka, Atsuyuki Watanabe, Tadao Aikawa, Koshiro Kanaoka, Hisato Takagi, Jose Wiley, et al. (+2)
7 [GO] 2023―Aug―29 Association between SARS-CoV-2 infection and new-onset atrial fibrillation Bar Rosh, Ibrahim Naoum, Ofra Barnett-Griness, Ronza Najjar-Debbiny, Walid Saliba
8 [GO] 2023―Jun―16 Predictive value of ASCVD risk score for mortality and major adverse cardiovascular events in the year following a COVID-19 infection among US veterans Eric T. Guardino, Laura Tarko, Peter W.F. Wilson, J. Michael Gaziano, Kelly Cho, David R. Gagnon, Ariela R. Orkaby
9 [GO] 2023―Mar―08 Post Covid-19 with myocarditis: A case report Nur Amalina Ramli, Mohan Raj Subramaniam, Norfarahdina Ramli, Saifullah Adam, Mohd Faiz Faizul Fauzi, Ng Kiah Loon, Khairul Amir Sayuti
10 [GO] 2023―Mar―08 Case report: COVID-19-related acute pericarditis mimicking acute anterior myocardial infarction Hazwani Ismail, Raja Abdul Wafy Bin Raja Muhammad Rooshdi
11 [GO] 2023―Mar―08 A comparison of clinical management and treatment outcome of ischemic stroke prior to and during Covid- 19 pandemic in Hospital Universiti Sains Malaysia S.A.A. Suliman, S.A. Halim
12 [GO] 2023―Feb―07 Pericarditis in long COVID-19 Roberto G. Carbone, Francesco Puppo
13 [GO] 2023―Jan―29 Should COVID-19 be considered cardiovascular disease risk equivalent? Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
14 [GO] 2022―Dec―22 Myocardial infarction with nonobstructive coronary arteries (MINOCA) in COVID-19 infection: A case report A. Suhaimi, N.M.A.S. Atan, S. Sukahri, Z.A. Abidin
15 [GO] 2022―Dec―22 Venous thromboembolism (VTE) and mortality among COVID-19 patients in the intensive care unit (ICU): Prevalence and risk factors H.H. Zulkifly, N.F. Mansor, I.A.H. Zaki, L.C. Kiok, K.S. Eng, T. Ravi, M. Pathmanathan
16 [GO] 2022―Dec―22 COVID-19 vaccination and myocardial infarction K.W. Koay, B.A. Zarina Banu, N.H. Tan, C.A. Goh, Shahul Hamid KAA, P.K. Kong, et al. (+2)
17 [GO] 2022―Dec―22 Acute pericarditis following mRNA COVID-19 vaccination: An unforeseen event Faiz Mashood, Noor Muhammad Azlan Shah, Samshol Sukahri, Imran Zainal Abidin
18 [GO] 2022―Dec―22 Booster COVID-19 vaccine comirnaty ignite supraventricular tachycardia in Wolff Parkinson White Syndrome H.Y. Kang, K.R. Narasamuloo, A.R. Silveraju, M.R. Mohd Said, C.W. Leong, A. Ibrahim, S. Krishinan
19 [GO] 2022―Dec―16 Increased risk of acute myocardial infarction after COVID-19 recovery: A systematic review and meta-analysis Marco Zuin, Gianluca Rigatelli, Valentina Battisti, Giulia Costola, Loris Roncon, Claudio Bilato
20 [GO] 2022―Dec―10 Acute pericarditis as a major clinical manifestation of long COVID-19 syndrome Frank Lloyd Dini, Umberto Baldini, Ibadete Bytyçi, Nicola Riccardo Pugliese, Gani Bajraktari, Michael Y. Henein
21 [GO] 2022―Dec―06 COVID-19 pandemic: National outbreak and acute coronary syndrome. Collateral damages? Ramón López-Palop, Íñigo Lozano, Pilar Carrillo
22 [GO] 2022―Nov―28 Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients - A retrospective cohort study on 5392 patients from a tertiary centre Petra Bistrovic, Anica Sabljic, Ivona Kovacevic, Tomislav Cikara, Tatjana Keres, Tomo Lucijanic, et al. (+4)
23 [GO] 2022―Nov―07 Covid-19 diagnosis and mortality in patients with non-ST-elevation myocardial infarction admitted in Italy during the national outbreak Leonardo De Luca, Stefano Rosato, Paola D'Errigo, Barbara Giordani, Gian Francesco Mureddu, Gabriella Badoni, et al. (+2)
24 [GO] 2022―Nov―02 NOX2 and NOX5 are increased in cardiac microvascular endothelium of deceased COVID-19 patients Zhu Jiang, Linghe Wu, Britt van der Leeden, Albert C. van Rossum, Hans W.M. Niessen, Paul A.J. Krijnen
25 [GO] 2022―Oct―05 The added predictive role of echocardiography in patients with mild or moderate Coronavirus Disease 2019 Lior Lupu, Ariel Banai, Yishay Szekely, Yael Lichter, Aviram Hochstadt, Philippe Taieb, et al. (+10)
26 [GO] 2022―Jul―21 Acute myocarditis following a third dose of COVID-19 mRNA vaccination in adults Anthony Simone, John Herald, Aiyu Chen, Rohith Nayak, Yuh-Jer Albert Shen, Ming-Sum Lee
27 [GO] 2022―Jul―13 Cardiovascular symptom phenotypes of post-acute sequelae of SARS-CoV-2 Zainab Mahmoud, Lauren East, Marye Gleva, Pamela K. Woodard, Kory Lavine, Amanda K. Verma
28 [GO] 2022―Jun―22 The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE heart failure care network Martin R. Cowie, Ricardo Mourilhe-Rocha, Hung-Yu Chang, Maurizio Volterrani, Ha Ngoc Ban, Denilson Campos de Albuquerque, et al. (+14)
29 [GO] 2022―May―26 SARS-CoV-2 infects human cardiac myocytes promoted by inflammation and oxidative stress Melina Tangos, Heidi Budde, Detmar Kolijn, Marcel Sieme, Saltanat Zhazykbayeva, Mária Lódi, et al. (+21)
30 [GO] 2022―May―14 Changes in the cardiovascular system in children with pediatric multisystem inflammatory syndrome temporally associated with COVID-19 - A single center experience. Aleksandra Stasiak, Piotr Kędziora, Beata Kierzkowska, Katarzyna Niewiadomska-Jarosik, Ewelina Perdas, Elżbieta Smolewska
31 [GO] 2022―Apr―30 Assessment of elevated high-sensitivity troponin T to predict different mortality risks in patients with COVID-19 Ping Wang, Rong Wang, Xue Feng, Juanjuan Tang, Jiali Zhang
32 [GO] 2022―Apr―15 Temporal relationship of myocarditis and pericarditis following COVID-19 vaccination: A pragmatic approach Cleo Anastassopoulou, Sophia Hatziantoniou, Charalambos Vlachopoulos, Nicholas Spanakis, Costas Tsioufis, Athanasios Tsakris, George Lazaros
33 [GO] 2022―Mar―11 Myocarditis after RNA-based COVID-19 vaccines: Where do we stand? Francesco Moroni, James Mbualungu, Antonio Abbate
34 [GO] 2022―Mar―11 The new pandemic: ACHD HF Jolanda Sabatino, Giovanni Di Salvo
35 [GO] 2022―Feb―27 Stress-testing interventional cardiology organization to streamline procedures during COVID-19 pandemic, and beyond Flavio Airoldi, Davide Tavano, Giuseppe Ambrosio
36 [GO] 2022―Jan―23 Factors influencing medical care of STEMI patients during the COVID-19 pandemic worldwide Peter Ong, Sebastian Allgäuer
37 [GO] 2022―Jan―22 Transcatheter aortic valve implantation during COVID-19 pandemic: An optimized model to relieve healthcare system overload Claudia Reddavid, Giuliano Costa, Roberto Valvo, Enrico Criscione, Orazio Strazzieri, Silvia Motta, et al. (+7)
38 [GO] 2022―Jan―22 Myocarditis after RNA-based vaccines for coronavirus. Alberto Cordero, Diego Cazorla, David Escribano, Mª. Amparo Quintanilla, José Mª. López-Ayala, Patricio Pérez Berbel, Vicente Bertomeu-González
39 [GO] 2022―Jan―01 Cardiac injury after COVID-19: Primary cardiac and primary non-cardiac etiology makes a difference Bernhard Metzler, Ivan Lechner, Martin Reindl, Sebastian J. Reinstadler
40 [GO] 2021―Dec―31 Clinical outcome of COVID-19 patients with cardiac disease in Queen Elizabeth Hospital Sabah J.H. Foo, C.H. Yen, J. Khaw, H.K. Ho, W.L. Chong, T.H. Toh, et al. (+2)
41 [GO] 2021―Dec―31 A novel pharyngeal sampling platform for COVID-19 testing prior to elective invasive cardiac lab procedure H. Sani, A. Mat Asis, A.N. Musa, R. Iskandar, K.S. Ibrahim, M.H.M. Hamidi, et al. (+4)
42 [GO] 2021―Dec―29 Patients hospitalised with heart failure across different waves of the COVID-19 pandemic show consistent clinical characteristics and outcomes IrfanA. Rind, Antonio Cannata, Benedict McDonaugh, Barbara Cassimon, Clare Bannister, Paul A. Scott, et al. (+3)
43 [GO] 2021―Dec―21 Distinct etiologies of high-sensitivity troponin T elevation predict different mortality risks for patients hospitalized with COVID-19 Pegah Khaloo, Ayman Shaqdan, Pablo A. Ledesma, Uwajachukwumma A. Uzomah, Leon M. Ptaszek, Jeremy N. Ruskin
44 [GO] 2021―Dec―03 Cardiac inflammation and microvascular procoagulant changes are decreased in second wave compared to first wave deceased COVID-19 patients Linghe Wu, Umit Baylan, Britt van der Leeden, Bernadette Schurink, Eva Roos, Casper G. Schalkwijk, et al. (+10)
45 [GO] 2021―Dec―02 Mechanical complications after STEMI: Another collateral damage of the COVID-19 pandemic Holzknecht Magdalena, Klug Gert, Metzler Bernhard, Reinstadler J. Sebastian
46 [GO] 2021―Nov―30 Endothelial dysfunction and COVID-19: What's the true impact on surrogate outcomes? Dimitrios Patoulias, Christodoulos Papadopoulos, Michael Doumas
47 [GO] 2021―Nov―24 Endothelial dysfunction in COVID-19: A potential predictor of long-COVID? Andreas Seitz, Peter Ong
48 [GO] 2021―Nov―16 Echocardiography in the time of Covid-19: Ultrasound enhancing agents save time and augment diagnostic information Dylan Sperling, Ashton C. Lai, Solomon W. Bienstock, Rajeev Samtani, Frans Beerkens, Mohanchandran Satish, et al. (+11)
49 [GO] 2021―Nov―12 Further evidence for the use of aspirin in COVID-19 Udaya S. Tantry, Kevin P. Bliden, Paul A. Gurbel
50 [GO] 2021―Nov―03 Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis Francesco Sofi, Monica Dinu, GianPaolo Reboldi, Fabrizio Stracci, Roberto F.E. Pedretti, Serafina Valente, et al. (+3)
51 [GO] 2021―Oct―25 In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19 Hernan Mejia-Renteria, Alejandro Travieso, Adam Sagir, Eduardo Martínez-Gómez, Angela Carrascosa-Granada, Takumi Toya, et al. (+4)
52 [GO] 2021―Oct―05 Pre-admission acetylsalicylic acid therapy and impact on in-hospital outcome in COVID-19 patients: The ASA-CARE study Antonio Sisinni, Luca Rossi, Antonio Battista, Enrico Poletti, Federica Battista, Rosa Alessia Battista, et al. (+12)
53 [GO] 2021―Sep―27 Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era Wen-Xiu Leng, Yue-Jin Yang
54 [GO] 2021―Sep―21 Severe COVID-19 vaccine associated myocarditis: Zebra or unicorn? Nicholas S. Hendren, Spencer Carter, Justin L. Grodin
55 [GO] 2021―Sep―17 Exercise ventilatory inefficiency may be a relevant CPET-feature in COVID-19 survivors Ernesto Crisafulli, Gianluigi Dorelli, Giulia Sartori, Luca Dalle Carbonare
56 [GO] 2021―Aug―31 Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID) Maurizio Dondi, Elisa Milan, Gianluca Pontone, Cole B. Hirschfeld, Michelle Williams, Leslee J. Shaw, et al. (+11)
57 [GO] 2021―Aug―18 Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients Antonio Abbate, Josh Gavin, Nima Madanchi, Christin Kim, Pranav R. Shah, Katherine Klein, et al. (+3)
58 [GO] 2021―Aug―02 Troponin elevation in COVID-19 patients: An important stratification biomarker with still some open questions Alessandro Maloberti, Marco Biolcati, Cristina Giannattasio
59 [GO] 2021―Jul―31 A fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era Javeria Jamal, Aiden O'Loughlin, John K. French
60 [GO] 2021―Jul―30 Genetic factors may affect the severity of COVID-19 Zhenzhen Zheng, Yuanming Zhou, Xishi Sun, Zhiqiang Wang, Chaoyu Wang, Jiangpeng Lin, et al. (+6)
61 [GO] 2021―Jul―24 Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up Piero Clavario, Vincenzo De Marzo, Roberta Lotti, Cristina Barbara, Annalisa Porcile, Carmelo Russo, et al. (+11)
62 [GO] 2021―Jul―21 Multimodality evaluation of cardiac injury in COVID-19: Getting to the heart of the matter Felice Gragnano, Arturo Cesaro, Francesco Pelliccia, Paolo Calabrò
63 [GO] 2021―Jul―03 Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up Viviana Maestrini, Lucia Ilaria Birtolo, Marco Francone, Gioacchino Galardo, Nicola Galea, Paolo Severino, et al. (+74)
64 [GO] 2021―Jun―19 Prevalence and characteristics of myocardial injury during COVID-19 pandemic: A new role for high-sensitive troponin Alessandro Maino, Enrico Di Stasio, Maria Chiara Grimaldi, Luigi Cappannoli, Erica Rocco, Rocco Vergallo, et al. (+5)
65 [GO] 2021―May―31 A prospective study on the consequences of SARS-CoV-2 infection on the heart of young adult competitive athletes: Implications for a safe return-to-play Luna Cavigli, Federica Frascaro, Francesca Turchini, Nicola Mochi, Patrizio Sarto, Stefano Bianchi, et al. (+7)
66 [GO] 2021―May―15 Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19 Xue-Ting Li, Mi-Wen Zhang, Zhen-Zhou Zhang, Yu-Dan Cao, Xiao-Yan Liu, Ran Miao, et al. (+8)
67 [GO] 2021―May―08 The role of sex and inflammation in cardiovascular outcomes and mortality in COVID-19 Anum Minhas, Julie K. Shade, Sung-Min Cho, Erin D. Michos, Thomas Metkus, Nisha A. Gilotra, et al. (+3)
68 [GO] 2021―Apr―24 Direct and indirect effects of COVID-19 on acute coronary syndromes: Can we pick the worst? Martino Pepe, Giacomo Frati, Giuseppe Biondi-Zoccai, Nicola Corcione, Arturo Giordano
69 [GO] 2021―Apr―19 How much is good enough? Insights from myocardial infarction incidence during COVID-19 pandemic Artur Fedorowski, David Erlinge
70 [GO] 2021―Mar―29 Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry Fabrizio D'Ascenzo, Ovidio De Filippo, Andrea Borin, Lucia Barbieri, Marianna Adamo, Nuccia Morici, et al. (+22)
71 [GO] 2021―Mar―29 Making things right! Shouldn't we screen patients with thromboembolic events for SARS-CoV-2 infection, during the pandemia? C. de Roquetaillade, B.G. Chousterman, A. Mebazaa
72 [GO] 2021―Mar―23 Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy Andrea Rognoni, Fabrizio D'Ascenzo, Martina Solli, Marco G. Mennuni, Vincenzo Galiffa, Roberta Rosso, et al. (+18)
73 [GO] 2021―Mar―08 Reply to: Assessment of administering antithrombosis in COVID-19 patients with acute hypoxemic respiratory failure Marco Schiavone, Alessio Gasperetti, Cecilia Gobbi, Mattia Busana, Giovanni B. Forleo
74 [GO] 2021―Feb―22 Response to Zhou et al. regarding Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19) Alexander Tan, Daniel M. Jones, Mahmood Ahmad
75 [GO] 2021―Feb―22 Reply to: RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO? Caroline Bleakley, Suveer Singh, Antonio de Marvao, Marco Morosin, Emmanouil Androulakis, Antonio Cannata, Susanna Price
76 [GO] 2021―Feb―22 Assessment of administering antithrombosis in COVID-19 patients with acute hypoxemic respiratory failure Ping Wang, Rong Wang, Juanjuan Tang, Yang Li, Jinjun Ma
77 [GO] 2021―Jan―30 Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2 Òscar Miró, Pere Llorens, Sònia Jiménez, Pascual Piñera, Guillermo Burillo, Alfonso Martín, et al. (+112)
78 [GO] 2021―Jan―29 Reply to Letter to the Editor - in response to: Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19). Wenqian Zhou, Yushi Wang, Yang Zheng
79 [GO] 2021―Jan―29 Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study Baptiste Maille, Marie Wilkin, Matthieu Millon, Noémie Rességuier, Frédéric Franceschi, Linda Koutbi-Franceschi, et al. (+8)
80 [GO] 2021―Jan―28 RV dysfunction in Covid-19 ARDS: Is there a difference in the impact of mechanical ventilation and ECMO? Vasiliki Tsolaki, George E. Zakynthinos
81 [GO] 2021―Jan―27 Does anticoagulation reduce mortality in patients with atrial fibrillation who later developed a COVID-19 infection? Juan Tamargo
82 [GO] 2020―Dec―30 Interplay between COVID-19, pollution, and weather features on changes in the incidence of acute coronary syndromes in early 2020 Francesco Versaci, Achille Gaspardone, Alessandro Danesi, Fabio Ferranti, Massimo Mancone, Enrica Mariano, et al. (+16)
83 [GO] 2020―Dec―11 Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study Gentian Denas, Nicola Gennaro, Eliana Ferroni, Ugo Fedeli, Giulia Lorenzoni, Dario Gregori, et al. (+2)
84 [GO] 2020―Dec―08 Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment-elevation myocardial infarction during the COVID-19 pandemic-The experience from the largest cardiovascular-specific centre in China Wen-Xiu Leng, Jin-Gang Yang, Xiang-Dong Li, Wen-Yang Jiang, Li-Jian Gao, Yuan Wu, et al. (+5)
85 [GO] 2020―Dec―02 Challenges in activation of remote monitoring in patients with cardiac rhythm devices during the coronavirus (COVID-19) pandemic Angelo Auricchio, Giulio Conte, Andrea Demarchi, Enrico Baldi, Tardu Ozkartal, Francois Regoli, Tiziano Moccetti
86 [GO] 2020―Nov―27 Cardiovascular screening of athletes during the COVID-19 pandemic: The (ir)relevance of elevated cardiac troponins Caroline M. Van De Heyning, Hielko Miljoen
87 [GO] 2020―Nov―25 Letter to the Editor - in response to: Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19) Alexander Tan, Daniel M. Jones, Mahmood Ahmad
88 [GO] 2020―Nov―25 Reply to “Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link” Islam Y. Elgendy, Carl J. Pepine
89 [GO] 2020―Nov―23 Right ventricular dysfunction in critically ill COVID-19 ARDS Caroline Bleakley, Suveer Singh, Benjamin Garfield, Marco Morosin, Elena Surkova, Ms Sundhiya Mandalia, et al. (+11)
90 [GO] 2020―Nov―23 Interpretation of elevated high-sensitivity cardiac troponin I in elite soccer players previously infected by severe acute respiratory syndrome coronavirus 2 Giuseppe Mascia, Fabio Pescetelli, Amedeo Baldari, Piero Gatto, Sara Seitun, Paolo Sartori, et al. (+4)
91 [GO] 2020―Nov―10 From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19 R. Vinci, D. Pedicino, F. Andreotti, G. Russo, A. D'Aiello, R. De Cristofaro, et al. (+2)
92 [GO] 2020―Oct―26 Myocardial injury in COVID-19: When observations become reality Giacomo Veronese, Dario Winterton, Enrico Ammirati
93 [GO] 2020―Oct―22 Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19) Wenqian Zhou, Ling Song, Xiang Wang, Zheng Xu, Shudong Wang, Jiqun Wang, et al. (+3)
94 [GO] 2020―Oct―20 COVID-19 and arterial thrombosis: A potentially fatal combination Francesco Moroni, Luca Baldetti
95 [GO] 2020―Oct―16 Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problem Fresse Audrey, Viard Delphine, Romani Serena, Gerard Alexandre, Lepelley Marion, Rocher Fanny, et al. (+2)
96 [GO] 2020―Oct―08 Extent of lung involvement over severity of cardiac disease for the prediction of adverse outcome in COVID-19 patients with cardiovascular disease Daniele Andreini, Edoardo Conte, Saima Mushtaq, Carlo Gigante, Maria Elisabetta Mancini, Andrea Annoni, et al. (+6)
97 [GO] 2020―Sep―28 Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence- Cosmo Godino, Andrea Scotti, Norma Maugeri, Nicasio Mancini, Evgeny Fominskiy, Alberto Margonato, Giovanni Landoni
98 [GO] 2020―Sep―25 The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern Italy Antonio Desai, Giuseppe Voza, Silvia Paiardi, Francesca Ilaria Teofilo, Giuseppe Caltagirone, Marta Ripoll Pons, et al. (+13)
99 [GO] 2020―Sep―23 Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia Chongtu YangMD, Fen LiuMD, Wei LiuMD, Guijuan CaoMD, Jiacheng LiuMD, Songjiang HuangMD, et al. (+4)
100 [GO] 2020―Sep―19 Assessing QT interval in COVID-19 patients: Safety of Hydroxychloroquine-azithromycin combination regimen Andrea Bernardini, Giuseppe Ciconte, Gabriele Negro, Roberto Rondine, Valerio Mecarocci, Tommaso Viva, et al. (+10)
101 [GO] 2020―Sep―10 Unusual arterial thrombotic events in Covid-19 patients C. de Roquetaillade, B.G. Chousterman, D. Tomasoni, M. Zeitouni, E. Houdart, A. Guedon, et al. (+6)
102 [GO] 2020―Sep―10 Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link Jef Van den Eynde, Keir R.G. McCutcheon
103 [GO] 2020―Sep―08 Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience Marco Schiavone, Alessio Gasperetti, Massimo Mancone, Antonio Curnis, Giosuè Mascioli, Gianfranco Mitacchione, et al. (+6)
104 [GO] 2020―Sep―01 Impact of COVID-19 lockdown on lifestyle adherence in stay-at-home patients with chronic coronary syndromes: Towards a time bomb. Amélie Cransac-Miet, Marianne Zeller, Frédéric Chagué, Agnès Soudry Faure, Florence Bichat, Nicolas Danchin, et al. (+2)
105 [GO] 2020―Aug―25 Catheterization laboratory activity before and during COVID-19 spread: A comparative analysis in Piedmont, Italy, by the Italian Society of Interventional Cardiology (GISE) Giorgio Quadri, Andrea Rognoni, Enrico Cerrato, Giorgio Baralis, Giacomo Boccuzzi, Elvis Brsic, et al. (+19)
106 [GO] 2020―Aug―13 Women's perspective on the COVID-19 pandemic: Walking into a post-peak phase Jolanda Sabatino, Sara Moscatelli, Yasmin Rustamova, Irina Kotlar, Martina Avesani, Margarita Brida, et al. (+8)
107 [GO] 2020―Jul―30 Systematic review of the role of renin-angiotensin system inhibitors in late studies on Covid-19: A new challenge overcome? Massimo Volpe, Allegra Battistoni
108 [GO] 2020―Jul―25 HIIT: A potential rehabilitation treatment in COVID-19 pneumonia with heart disease Yunzhao Li, Di Liu, Hui Wu
109 [GO] 2020―Jul―13 The cardiovascular burden of congenital heart disease - not only in times of COVID-19 Jan Müller, Leon Brudy, Michael Meyer, Peter Ewert, Renate Oberhoffer
110 [GO] 2020―Jul―04 Acute pulmonary embolism in COVID-19 disease Serdar Kalemci, Aydın Sarıhan, Arife Zeybek, Ahmet Bülent Kargi
111 [GO] 2020―Jun―28 COVID-19 trials in Italy: A call for simplicity, top standards and global pooling Aldo P. Maggioni, Felicita Andreotti, Cristina Gervasoni, Giuseppe Di Pasquale
112 [GO] 2020―Jun―19 Triage and management of the ACHD patient with COVID-19: A single center approach Lauren T. Lastinger, Curt J. Daniels, Marc Lee, Aarthi Sabanayagam, Elisa A. Bradley
113 [GO] 2020―Jun―16 COVID-19 myocardial injury: We have much more to discover Dimitrios A. Vrachatis, Sotiria G. Giotaki, Georgios Giannopoulos
114 [GO] 2020―Jun―16 Cardiac involvement of COVID-19: Looking forward to novel discoveries and clinically valuable evidence Bo Hu, Qing Deng, Qing Zhou
115 [GO] 2020―Jun―03 COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment? Lorenzo Loffredo, Francesco Violi
116 [GO] 2020―May―29 Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research Maria Frigerio
117 [GO] 2020―May―29 Response to the letter, “The cardiovascular burden of congenital heart disease - not only in times of COVID-19” Weiyi Tan, Jamil Aboulhosn
118 [GO] 2020―May―26 Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients Pompilio Faggiano, Andrea Bonelli, Sara Paris, Giuseppe Milesi, Stefano Bisegna, Nicola Bernardi, et al. (+3)
119 [GO] 2020―May―19 Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin Alberto Cipriani, Alessandro Zorzi, Davide Ceccato, Federico Capone, Matteo Parolin, Filippo Donato, et al. (+10)
120 [GO] 2020―May―11 Why are women better protected from COVID-19: Clues for men? Sex and COVID-19 Islam Y. Elgendy, Carl J. Pepine
121 [GO] 2020―Apr―25 Centralization of the ST elevation myocardial infarction care network in the Lombardy region during the COVID-19 outbreak Marco Ferlini, Aida Andreassi, Stefano Carugo, Claudio Cuccia, Beatrice Bianchini, Battistina Castiglioni, et al. (+12)
122 [GO] 2020―Apr―11 More clinical warning indicators should be explored for monitoring COVID-19 patients' condition Chaojun Yang, Jian Yang, Jing Zhang, Jun Yang
123 [GO] 2020―Apr―08 Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China Qing Deng, Bo Hu, Yao Zhang, Hao Wang, Xiaoyang Zhou, Wei Hu, et al. (+4)
124 [GO] 2020―Apr―06 SARS-CoV-2 inflames the heart. The importance of awareness of myocardial injury in COVID-19 patients Enrico Ammirati, Dao Wen Wang
125 [GO] 2020―Apr―06 An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients Jing-Zhang Wang, Rui-Ying Zhang, Jing Bai
126 [GO] 2020―Apr―04 The globe on the spotlight: Coronavirus disease 2019 (Covid-19) Margarita Brida, Massimo Chessa, Hong Gu, Michael A. Gatzoulis
127 [GO] 2020―Mar―31 Commentary: What is the relationship between Covid-19 and cardiovascular disease? R. Ferrari, G. Di Pasquale, C. Rapezzi
128 [GO] 2020―Mar―28 The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease Weiyi Tan, Jamil Aboulhosn
 [1] 

128 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.018 sec